Exclusions from the Section 301 tariffs on imports from China for 81 medical care products needed to address the COVID-19 pandemic have been extended from Feb. 28 through May 15, 2023. These exclusions are available for any product that meets the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request.
In addition, the Office of the U.S. Trade Representative is accepting comments through March 7 on whether to extend some or all of these exclusions for up to another six months.
In the meantime, USTR is evaluating comments submitted as part of a review of all Section 301 tariffs on imports from China, which could result in changes to those tariffs later this year.
In addition, efforts to ameliorate the impact of these tariffs are continuing.
- ST&R is advocating for the renewal of all previously approved exclusions and the creation of a process allowing for new exclusion requests (for more information, please contact email@example.com).
- There are a number of proven and legitimate ways to effectively avoid the tariffs or limit their impact (click here for more information).
- Importers of List 3 and 4A goods from China can still preserve their rights to possible refunds of tariffs paid on such goods by joining an ongoing court case (for more information, or assistance filing a claim, please contact us at 301Litigation@strtrade.com).
Copyright © 2023 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.